Theresa Medina, MD, discusses the clinical potential of lifileucel, a tumor-infiltrating lymphocyte therapy, for patients with advanced melanoma.
Theresa Medina, MD
Advertisement
Theresa Medina, MD, is an associate professor of medicine-medical oncology at the University of Colorado Cancer Center, Anschutz Medical Campus.
Articles by Theresa Medina, MD
Theresa Medina, MD, discusses the C-144-01 study of lifileucel in patients with advanced melanoma.
Theresa Medina, MD, discusses treatment with lifileucel in patients with advanced melanoma and the background of the C-144-01 study.
Advertisement
Latest Updated Articles
Medina Covers the C-144-01 Study: Lifileucel in Advanced MelanomaPublished: June 28th 2025 | Updated:
- Behind the C-144-01 Study of Lifileucel in Melanoma
Published: June 6th 2025 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
